Report cover image

Global Children Influenza Vaccine Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 193 Pages
SKU # APRC20361675

Description

Summary

According to APO Research, The global Children Influenza Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Children Influenza Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Children Influenza Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Children Influenza Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Children Influenza Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Children Influenza Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Children Influenza Vaccine sales, projected growth trends, production technology, application and end-user industry.

Children Influenza Vaccine Segment by Company

BCHT
CCBIO
CSL
Hulan Bio
KM Biologics
Sanofi Pasteur
Sinovac
Viatris
AstraZeneca
GSK
Jiangsu GDK
Children Influenza Vaccine Segment by Type

Nasal Spray
Injection
Children Influenza Vaccine Segment by Application

Public
Private
Children Influenza Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Children Influenza Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Children Influenza Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Children Influenza Vaccine Market by Type
1.2.1 Global Children Influenza Vaccine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Nasal Spray
1.2.3 Injection
1.3 Children Influenza Vaccine Market by Application
1.3.1 Global Children Influenza Vaccine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Children Influenza Vaccine Market Dynamics
2.1 Children Influenza Vaccine Industry Trends
2.2 Children Influenza Vaccine Industry Drivers
2.3 Children Influenza Vaccine Industry Opportunities and Challenges
2.4 Children Influenza Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Children Influenza Vaccine Revenue Estimates and Forecasts (2020-2031)
3.2 Global Children Influenza Vaccine Revenue by Region
3.2.1 Global Children Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Children Influenza Vaccine Revenue by Region (2020-2025)
3.2.3 Global Children Influenza Vaccine Revenue by Region (2026-2031)
3.2.4 Global Children Influenza Vaccine Revenue Market Share by Region (2020-2031)
3.3 Global Children Influenza Vaccine Sales Estimates and Forecasts 2020-2031
3.4 Global Children Influenza Vaccine Sales by Region
3.4.1 Global Children Influenza Vaccine Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Children Influenza Vaccine Sales by Region (2020-2025)
3.4.3 Global Children Influenza Vaccine Sales by Region (2026-2031)
3.4.4 Global Children Influenza Vaccine Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Children Influenza Vaccine Revenue by Manufacturers
4.1.1 Global Children Influenza Vaccine Revenue by Manufacturers (2020-2025)
4.1.2 Global Children Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Children Influenza Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Children Influenza Vaccine Sales by Manufacturers
4.2.1 Global Children Influenza Vaccine Sales by Manufacturers (2020-2025)
4.2.2 Global Children Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Children Influenza Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Children Influenza Vaccine Sales Price by Manufacturers (2020-2025)
4.4 Global Children Influenza Vaccine Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Children Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Children Influenza Vaccine Manufacturers, Product Type & Application
4.7 Global Children Influenza Vaccine Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Children Influenza Vaccine Market CR5 and HHI
4.8.2 2024 Children Influenza Vaccine Tier 1, Tier 2, and Tier 3
5 Children Influenza Vaccine Market by Type
5.1 Global Children Influenza Vaccine Revenue by Type
5.1.1 Global Children Influenza Vaccine Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Children Influenza Vaccine Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Children Influenza Vaccine Revenue Market Share by Type (2020-2031)
5.2 Global Children Influenza Vaccine Sales by Type
5.2.1 Global Children Influenza Vaccine Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Children Influenza Vaccine Sales by Type (2020-2031) & (K Units)
5.2.3 Global Children Influenza Vaccine Sales Market Share by Type (2020-2031)
5.3 Global Children Influenza Vaccine Price by Type
6 Children Influenza Vaccine Market by Application
6.1 Global Children Influenza Vaccine Revenue by Application
6.1.1 Global Children Influenza Vaccine Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Children Influenza Vaccine Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Children Influenza Vaccine Revenue Market Share by Application (2020-2031)
6.2 Global Children Influenza Vaccine Sales by Application
6.2.1 Global Children Influenza Vaccine Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Children Influenza Vaccine Sales by Application (2020-2031) & (K Units)
6.2.3 Global Children Influenza Vaccine Sales Market Share by Application (2020-2031)
6.3 Global Children Influenza Vaccine Price by Application
7 Company Profiles
7.1 BCHT
7.1.1 BCHT Comapny Information
7.1.2 BCHT Business Overview
7.1.3 BCHT Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BCHT Children Influenza Vaccine Product Portfolio
7.1.5 BCHT Recent Developments
7.2 CCBIO
7.2.1 CCBIO Comapny Information
7.2.2 CCBIO Business Overview
7.2.3 CCBIO Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CCBIO Children Influenza Vaccine Product Portfolio
7.2.5 CCBIO Recent Developments
7.3 CSL
7.3.1 CSL Comapny Information
7.3.2 CSL Business Overview
7.3.3 CSL Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CSL Children Influenza Vaccine Product Portfolio
7.3.5 CSL Recent Developments
7.4 Hulan Bio
7.4.1 Hulan Bio Comapny Information
7.4.2 Hulan Bio Business Overview
7.4.3 Hulan Bio Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Hulan Bio Children Influenza Vaccine Product Portfolio
7.4.5 Hulan Bio Recent Developments
7.5 KM Biologics
7.5.1 KM Biologics Comapny Information
7.5.2 KM Biologics Business Overview
7.5.3 KM Biologics Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 KM Biologics Children Influenza Vaccine Product Portfolio
7.5.5 KM Biologics Recent Developments
7.6 Sanofi Pasteur
7.6.1 Sanofi Pasteur Comapny Information
7.6.2 Sanofi Pasteur Business Overview
7.6.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio
7.6.5 Sanofi Pasteur Recent Developments
7.7 Sinovac
7.7.1 Sinovac Comapny Information
7.7.2 Sinovac Business Overview
7.7.3 Sinovac Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sinovac Children Influenza Vaccine Product Portfolio
7.7.5 Sinovac Recent Developments
7.8 Viatris
7.8.1 Viatris Comapny Information
7.8.2 Viatris Business Overview
7.8.3 Viatris Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Viatris Children Influenza Vaccine Product Portfolio
7.8.5 Viatris Recent Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Comapny Information
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 AstraZeneca Children Influenza Vaccine Product Portfolio
7.9.5 AstraZeneca Recent Developments
7.10 GSK
7.10.1 GSK Comapny Information
7.10.2 GSK Business Overview
7.10.3 GSK Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 GSK Children Influenza Vaccine Product Portfolio
7.10.5 GSK Recent Developments
7.11 Jiangsu GDK
7.11.1 Jiangsu GDK Comapny Information
7.11.2 Jiangsu GDK Business Overview
7.11.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
7.11.5 Jiangsu GDK Recent Developments
8 North America
8.1 North America Children Influenza Vaccine Market Size by Type
8.1.1 North America Children Influenza Vaccine Revenue by Type (2020-2031)
8.1.2 North America Children Influenza Vaccine Sales by Type (2020-2031)
8.1.3 North America Children Influenza Vaccine Price by Type (2020-2031)
8.2 North America Children Influenza Vaccine Market Size by Application
8.2.1 North America Children Influenza Vaccine Revenue by Application (2020-2031)
8.2.2 North America Children Influenza Vaccine Sales by Application (2020-2031)
8.2.3 North America Children Influenza Vaccine Price by Application (2020-2031)
8.3 North America Children Influenza Vaccine Market Size by Country
8.3.1 North America Children Influenza Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Children Influenza Vaccine Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Children Influenza Vaccine Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Children Influenza Vaccine Market Size by Type
9.1.1 Europe Children Influenza Vaccine Revenue by Type (2020-2031)
9.1.2 Europe Children Influenza Vaccine Sales by Type (2020-2031)
9.1.3 Europe Children Influenza Vaccine Price by Type (2020-2031)
9.2 Europe Children Influenza Vaccine Market Size by Application
9.2.1 Europe Children Influenza Vaccine Revenue by Application (2020-2031)
9.2.2 Europe Children Influenza Vaccine Sales by Application (2020-2031)
9.2.3 Europe Children Influenza Vaccine Price by Application (2020-2031)
9.3 Europe Children Influenza Vaccine Market Size by Country
9.3.1 Europe Children Influenza Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Children Influenza Vaccine Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Children Influenza Vaccine Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Children Influenza Vaccine Market Size by Type
10.1.1 China Children Influenza Vaccine Revenue by Type (2020-2031)
10.1.2 China Children Influenza Vaccine Sales by Type (2020-2031)
10.1.3 China Children Influenza Vaccine Price by Type (2020-2031)
10.2 China Children Influenza Vaccine Market Size by Application
10.2.1 China Children Influenza Vaccine Revenue by Application (2020-2031)
10.2.2 China Children Influenza Vaccine Sales by Application (2020-2031)
10.2.3 China Children Influenza Vaccine Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Children Influenza Vaccine Market Size by Type
11.1.1 Asia Children Influenza Vaccine Revenue by Type (2020-2031)
11.1.2 Asia Children Influenza Vaccine Sales by Type (2020-2031)
11.1.3 Asia Children Influenza Vaccine Price by Type (2020-2031)
11.2 Asia Children Influenza Vaccine Market Size by Application
11.2.1 Asia Children Influenza Vaccine Revenue by Application (2020-2031)
11.2.2 Asia Children Influenza Vaccine Sales by Application (2020-2031)
11.2.3 Asia Children Influenza Vaccine Price by Application (2020-2031)
11.3 Asia Children Influenza Vaccine Market Size by Country
11.3.1 Asia Children Influenza Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Children Influenza Vaccine Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Children Influenza Vaccine Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Children Influenza Vaccine Market Size by Type
12.1.1 SAMEA Children Influenza Vaccine Revenue by Type (2020-2031)
12.1.2 SAMEA Children Influenza Vaccine Sales by Type (2020-2031)
12.1.3 SAMEA Children Influenza Vaccine Price by Type (2020-2031)
12.2 SAMEA Children Influenza Vaccine Market Size by Application
12.2.1 SAMEA Children Influenza Vaccine Revenue by Application (2020-2031)
12.2.2 SAMEA Children Influenza Vaccine Sales by Application (2020-2031)
12.2.3 SAMEA Children Influenza Vaccine Price by Application (2020-2031)
12.3 SAMEA Children Influenza Vaccine Market Size by Country
12.3.1 SAMEA Children Influenza Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Children Influenza Vaccine Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Children Influenza Vaccine Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Children Influenza Vaccine Value Chain Analysis
13.1.1 Children Influenza Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Children Influenza Vaccine Production Mode & Process
13.2 Children Influenza Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Children Influenza Vaccine Distributors
13.2.3 Children Influenza Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.